Total Payments
$1,192
2024 Payments
$32.99
Companies
17
Transactions
94
Medicare Patients
8,726
Medicare Billing
$740,748
Payment Breakdown by Category
Food & Beverage$1,192 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,192 | 94 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $657.81 | 58 | $0 (2020) |
| Genentech USA, Inc. | $158.23 | 11 | $0 (2020) |
| Teva Pharmaceuticals USA, Inc. | $48.71 | 4 | $0 (2018) |
| Regeneron Healthcare Solutions, Inc. | $46.76 | 3 | $0 (2023) |
| JAZZ PHARMACEUTICALS INC. | $44.29 | 3 | $0 (2019) |
| Allergan Inc. | $37.12 | 2 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $28.45 | 2 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $25.79 | 2 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $24.79 | 1 | $0 (2017) |
| Amgen Inc. | $17.97 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $32.99 | 2 | Amgen Inc. ($17.97) |
| 2023 | $46.76 | 3 | Regeneron Healthcare Solutions, Inc. ($46.76) |
| 2021 | $13.43 | 1 | AstraZeneca Pharmaceuticals LP ($13.43) |
| 2020 | $65.62 | 5 | GlaxoSmithKline, LLC. ($51.44) |
| 2019 | $412.25 | 35 | GlaxoSmithKline, LLC. ($273.44) |
| 2018 | $300.86 | 23 | GlaxoSmithKline, LLC. ($206.50) |
| 2017 | $320.36 | 25 | GlaxoSmithKline, LLC. ($126.43) |
All Payment Transactions
94 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: Respiratory | ||||||
| 09/04/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: Inflammation | ||||||
| 06/30/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/06/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 03/27/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/24/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: Respiratory | ||||||
| 03/31/2020 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.10 | General |
| Category: RESPIRATORY | ||||||
| 03/10/2020 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: RESPIRATORY | ||||||
| 03/02/2020 | GlaxoSmithKline, LLC. | BREO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: RESPIRATORY | ||||||
| 02/19/2020 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: Immunology | ||||||
| 01/22/2020 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $11.94 | General |
| Category: RESPIRATORY | ||||||
| 12/05/2019 | JAZZ PHARMACEUTICALS INC. | SUNOSI (Drug) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: PAIN | ||||||
| 11/20/2019 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $13.05 | General |
| Category: RESPIRATORY | ||||||
| 10/23/2019 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: RESPIRATORY | ||||||
| 10/23/2019 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $3.82 | General |
| Category: RESPIRATORY | ||||||
| 10/22/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), ANORO | Food and Beverage | In-kind items and services | $11.19 | General |
| Category: RESPIRATORY | ||||||
| 10/09/2019 | JAZZ PHARMACEUTICALS INC. | SUNOSI (Drug) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: PAIN | ||||||
| 10/08/2019 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $2.87 | General |
| Category: RESPIRATORY | ||||||
| 10/08/2019 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $2.50 | General |
| Category: RESPIRATORY | ||||||
| 10/07/2019 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: Immunology | ||||||
| 10/04/2019 | ALK-Abello, Inc | Odactra (Drug) | Food and Beverage | In-kind items and services | $12.84 | General |
| Category: Allergy and Immunology | ||||||
| 09/14/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), ANORO | Food and Beverage | In-kind items and services | $10.05 | General |
| Category: RESPIRATORY | ||||||
| 09/11/2019 | JAZZ PHARMACEUTICALS INC. | SUNOSI (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: PAIN | ||||||
| 08/26/2019 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: RESPIRATORY | ||||||
| 08/21/2019 | Horizon Therapeutics plc | RAYOS (Drug), RAYOS, RAYOS | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: RAYOS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,757 | 2,221 | $584,992 | $160,486 |
| 2022 | 17 | 2,632 | 3,248 | $788,368 | $215,817 |
| 2021 | 18 | 2,579 | 3,161 | $747,209 | $211,584 |
| 2020 | 18 | 1,758 | 2,143 | $611,503 | $152,861 |
Total Patients
8,726
Total Services
10,773
Medicare Billing
$740,748
Procedure Codes
82
All Medicare Procedures & Services
82 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 498 | 806 | $292,766 | $84,346 | 28.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 132 | 132 | $72,732 | $17,900 | 24.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 102 | 164 | $56,252 | $16,351 | 29.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 121 | 139 | $34,333 | $10,179 | 29.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 45 | 47 | $22,889 | $6,951 | 30.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 20 | 36 | $26,136 | $5,990 | 22.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 38 | 38 | $27,854 | $5,561 | 20.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 27 | 27 | $18,657 | $5,162 | 27.7% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 257 | 273 | $7,644 | $1,832 | 24.0% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 197 | 211 | $6,541 | $1,533 | 23.4% |
| G0296 | Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) | Office | 2023 | 38 | 43 | $4,085 | $1,315 | 32.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 14 | 14 | $3,360 | $946.96 | 28.2% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 78 | 79 | $2,212 | $505.16 | 22.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 29 | $2,088 | $352.80 | 16.9% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 19 | 20 | $980.00 | $323.40 | 33.0% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 44 | 44 | $1,364 | $267.81 | 19.6% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Facility | 2023 | 32 | 32 | $1,312 | $262.08 | 20.0% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 28 | 30 | $1,290 | $243.63 | 18.9% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 34 | 34 | $1,462 | $233.28 | 16.0% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 22 | 23 | $1,035 | $231.84 | 22.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 526 | 860 | $312,180 | $94,187 | 30.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 221 | 425 | $144,403 | $36,892 | 25.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 149 | 149 | $82,099 | $20,195 | 24.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 84 | 85 | $62,238 | $14,501 | 23.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 44 | 68 | $49,368 | $12,676 | 25.7% |
About Dr. Edward Dimitry, MD
Dr. Edward Dimitry, MD is a Pulmonary Disease healthcare provider based in Summit, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/10/2005. The National Provider Identifier (NPI) number assigned to this provider is 1275534323.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Edward Dimitry, MD has received a total of $1,192 in payments from pharmaceutical and medical device companies, with $32.99 received in 2024. These payments were reported across 94 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($1,192).
As a Medicare-enrolled provider, Dimitry has provided services to 8,726 Medicare beneficiaries, totaling 10,773 services with total Medicare billing of $740,748. Data is available for 4 years (2020–2023), covering 82 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Pulmonary Disease
- Location Summit, NJ
- Active Since 08/10/2005
- Last Updated 02/03/2017
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1275534323
Products in Payments
- NUCALA (Biological) $235.84
- BREO (Drug) $156.71
- Xolair (Biological) $140.81
- TRELEGY ELLIPTA (Drug) $111.27
- ANORO (Drug) $92.93
- DUPIXENT (Biological) $46.76
- SUNOSI (Drug) $44.29
- QVAR (Drug) $35.05
- TEZSPIRE (Biological) $32.99
- LONHALA MAGNAIR (Drug) $25.79
- OFEV (Drug) $24.79
- AVYCAZ (Drug) $19.79
- GLASSIA (Biological) $17.71
- Esbriet (Biological) $17.42
- TEFLARO (Drug) $17.33
- XOLAIR (Biological) $14.82
- RAYOS (Drug) $14.35
- BREO ELLIPTA (Drug) $13.98
- CINQAIR (Drug) $13.66
- BREZTRI (Drug) $13.43
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Summit
Frederic Scoopo, Md, MD
Pulmonary Disease — Payments: $16,772
Pulmonary Disease $16,772
Federico Cerrone, M.d, M.D
Pulmonary Disease — Payments: $12,817
Pulmonary Disease $12,817
Christopher Decotiis, Md, MD
Pulmonary Disease — Payments: $6,340
Pulmonary Disease $6,340
Erwin Oei, Md, MD
Pulmonary Disease — Payments: $4,118
Pulmonary Disease $4,118
Chirag Shah, Md, MD
Pulmonary Disease — Payments: $909.09
Pulmonary Disease $909.09
Andrew Toscano, M.d, M.D
Pulmonary Disease — Payments: $760.34
Pulmonary Disease $760.34